Stock Price Quote

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE275.0511.2 (+4.24 %)
PREV CLOSE ( ) 263.85
OPEN PRICE ( ) 265.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 118778
TODAY'S LOW / HIGH ( )258.60 279.30
52 WK LOW / HIGH ( )206.45 350.05
NSE274.6010.75 (+4.07 %)
PREV CLOSE( ) 263.85
OPEN PRICE ( ) 263.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 274.60 (2289)
VOLUME 4367888
TODAY'S LOW / HIGH( ) 258.30 279.50
52 WK LOW / HIGH ( )202 350
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

02Apr Zydus Cadila gets final approval from
Zydus Cadila has received final approval from the US Food and Drug Admin..
30Mar Zydus Cadila gets tentative approval f
Zydus Cadila has received tentative approval from the USFDA to market Ca..
30Mar Cadila Healthcare inches up on getting
Cadila Healthcare is currently trading at Rs. 253.00, up by 0.20 points..
23Mar Cadila Healthcare trades higher on the
Cadila Healthcare is currently trading at Rs. 295.50, up by 9.40 points..
17Mar Cadila Healthcare trades in green on t
Cadila Healthcare is currently trading at Rs. 259.40, up by 10.05 points..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit281616021
Gross Profit 3218 19285
Operating Profit 454623667
Net Sales 1848664927

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  3864.65 (5.31%)
M.Cap ( in Cr)6415.08
Abbott India (BSE)
peergroup  15826.60 (1.20%)
M.Cap ( in Cr)33630.42
Sanofi India (BSE)
peergroup  6663.60 (2.77%)
M.Cap ( in Cr)15346.69
Torrent Pharma (BSE)
peergroup  2077.10 (5.95%)
M.Cap ( in Cr)35146.34
Lupin (BSE)
peergroup  654.80 (13.05%)
M.Cap ( in Cr)29662.32

Shareholding Pattern

PROMOTERS 74.88%
NON-INSTITUTION 7.8%
MUTUAL FUNDS/UTI 7.11%
FI/BANKS/INSURANCE 5.46%
GOVERNMENT 0.13%
FII 0%

About Cadila Healthcare Ltd.

Cadila Healthcare Ltd. was incorporated in the year 1995. Its today's share price is 263.85. Its current market capitalisation stands at Rs 28158.04 Cr. In the latest quarter, company has reported Gross Sales of Rs. 131656 Cr and Total Income of Rs.133718 Cr. The company's management includes Ganesh N Nayak, Sharvil P Patel, Bhadresh K Shah, Apurva S Diwanji, Dharmishta N Raval, Mukesh M Patel, Nitin R Desai, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of CADILAHC and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X